Candidiasis has increased substantially worldwide over recent decades and is a significant
cause of morbidity and mortality, especially among critically ill patients. Diabetes mellitus …

During recent decades, antifungal susceptibility testing has become standardized and
nowadays has the same role of the antibacterial susceptibility testing in microbiology …

Candida auris is an emerging multidrug-resistant fungal pathogen causing nosocomial and
invasive infections associated with high mortality. C. auris is commonly misidentified as …

Purpose Clinical data on patients with intra-abdominal candidiasis (IAC) is still scarce.
Methods We collected data from 13 hospitals in Italy, Spain, Brazil, and Greece over a 3 …

Candidemia and other forms of candidiasis are associated with considerable excess
mortality and costs. Despite the addition of several new antifungal agents with improved …

Despite the availability of newer antifungal drugs, outcomes for patients with invasive fungal
infections (IFIs) continue to be poor, in large part due to delayed diagnosis and initiation of …

Intensive care unit (ICU) practitioners and emergency department clinicians are in urgent
need of a major upgrade in their access to accurate and fast microbial diagnosis (Table 1) …

The advent of modern antimicrobial therapy following the discovery of penicillin during the
1940s yielded remarkable improvements in case fatality rate of serious infections including …

Objectives We sought to determine the impact of timing of appropriate antifungal therapy, as
assessed by susceptibility results, on patient survival. Methods Patients≥ 16 years of age …

Background To characterize and identify prognostic factors for 28-day mortality among
patients with hospital-acquired fungemia (HAF) in the Intensive Care Unit (ICU). Methods A …